The similar Myc expression levels in the Myc+/−;p53KO and Myc-WT;p53KO hemangiosarcomas and in thymic lymphomas suggested that equivalent but supraphysiological levels of Myc are needed for tumorigenesis in both genotypes. The gene discussed is MYC; the disease is angiosarcoma.